Valganciclovir Hydrochloride | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Valganciclovir Hydrochloride
Health Canada Patents

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Contact Supplier

Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Contact Supplier

FAMAR CDMO- From early development to commercial manufacturing.

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Valganciclovir Hydrochloride

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

41 API Suppliers, 22 USDMF, 3 CEP/COS, 10 EU WC, 19 NDC API, 20 Listed Suppliers, $ API Reference Price

41 API Suppliers
22 USDMF
3 CEP/COS
10 EU WC
19 NDC API
20 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

27 Drugs in Development

27 Drugs in Development

INTERMEDIATES

9 Intermediate Suppliers

9 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

91 FDF Dossiers, 18 FDA Orange Book, 45 Europe, 6 Canada, 9 Australia, 5 South Africa, 8 Listed Dossiers

91 FDF Dossiers
18 FDA Orange Book
45 Europe
6 Canada
9 Australia
5 South Africa
8 Listed Dossiers

RELATED EXCIPIENT COMPANIES

5 Rochem International Inc, 16 SPI Pharma, 2 Seqens, 4 DKSH, 1 Pharm-RX Chemical, 5 Faran Shimi Pharmaceutical, 4 Boai NKY Pharmaceuticals Ltd, 4 Gangwal Healthcare, 5 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 1 Capital Farma, 1 ACG Worldwide, 7 Actylis, 1 Aeon Procare, 4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Avesta Pharma, 24 BASF, 1 Bioplus Life Sciences, 2 Clariant, 10 Corel Pharma Chem, 2 DFE Pharma, 2 Finar, 11 Gangwal Chemicals, 7 Ideal Cures Pvt Ltd, 1 Ingredion Pharma Solutions, 19 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 13 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nomisma Healthcare, 3 Novo Excipients, 2 Pharmatrans-Sanaq, 5 Pluviaendo, 2 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 19 Roquette, 14 Seppic, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 9 Sigachi Industries, 2 The Dow Chemical Company, 1 Ulanqab Kema New Material, 1 Valens Pharmachem, 2 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

58 Fillers, Diluents & Binders, 53 Coating Systems & Additives, 35 Solubilizers, 30 Controlled & Modified Release, 26 Thickeners and Stabilizers, 24 Direct Compression, 20 Parenteral, 20 Taste Masking, 20 Topical, 18 Granulation, 17 Lubricants & Glidants, 16 Film Formers & Plasticizers, 14 Chewable & Orodispersible Aids, 13 Co-Processed Excipients, 11 Disintegrants & Superdisintegrants, 11 Emulsifying Agents, 8 API Stability Enhancers, 6 Surfactant & Foaming Agents, 5 Empty Capsules, 4 Rheology Modifiers, 4 Vegetarian Capsules, 4 Coloring Agents

58 Fillers, Diluents & Binders
53 Coating Systems & Additives
35 Solubilizers
30 Controlled & Modified Release
26 Thickeners and Stabilizers
24 Direct Compression
20 Parenteral
20 Taste Masking
20 Topical
18 Granulation
17 Lubricants & Glidants
16 Film Formers & Plasticizers
14 Chewable & Orodispersible Aids
13 Co-Processed Excipients
11 Disintegrants & Superdisintegrants
11 Emulsifying Agents
8 API Stability Enhancers
6 Surfactant & Foaming Agents
5 Empty Capsules
4 Rheology Modifiers
4 Vegetarian Capsules
4 Coloring Agents

DIGITAL CONTENT

31 NEWS #PharmaBuzz

31 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 16 Finished Drug Prices, 1 Annual Reports

2 US Medicaid Prescriptions
16 Finished Drug Prices
1 Annual Reports

MARKET PLACE

8 APIs, 10 FDF Dossiers

8 APIs
10 FDF Dossiers

PATENTS & EXCLUSIVITIES

2 US Patents, 2 Health Canada Patents

2 US Patents
2 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 USP, 2 Others

2 USP
2 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 1,717 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

2 All

01 2Gowling Lafleur Henderson LLP

filter Patent Reset all filters

2 All

01 22154721

filter Product Reset all filters

2 All

01 2Valganciclovir Hydrochloride

filter Dosage Reset all filters

2 All

01 1Powder for Oral Solution

02 1Tablet

filter Exp Date Reset all filters

2 All

01 22015-07-26

Product Main Page

01

Gowling Lafleur Henderson LLP

Valganciclovir Hydrochloride

BioAsia

Not Confirmed

Gowling Lafleur Henderson LLP

Canada

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2015-07-26

Date Granted : 2001-01-02

Valganciclovir Hydrochloride

Brand Name : VALCYTE

Patent Number : 2154721

Filing Date : 1995-07-26

Strength per Unit : 450 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2015-07-26

Date Granted : 2001-01-02

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Gowling Lafleur Henderson LLP

Valganciclovir Hydrochloride

BioAsia

Not Confirmed

Gowling Lafleur Henderson LLP

Canada

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2015-07-26

Date Granted : 2001-01-02

Valganciclovir Hydrochloride

Brand Name : VALCYTE

Patent Number : 2154721

Filing Date : 1995-07-26

Strength per Unit : 50 mg / ml

Dosage Form : Powder for Oral Solution

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2015-07-26

Date Granted : 2001-01-02

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
ASK US!